|
Proportion of hours during the intervention period with RI value <20, median
|
16
|
51
|
0.02
|
|
(1st, 3rd quartile; min–max)
|
(11, 45; 2–87)
|
(33, 72; 5–86)
|
|
RASS score at baseline, median
|
−4
|
−4
|
0.76
|
|
(1st, 3rd quartile; min-max)
|
(−4, −3; −5 to −2)
|
(−4, −3; −5 to 0)
|
|
Proportion of hours with RASS score −4 or −5 during intervention period, median
|
47
|
35
|
0.63
|
|
(1st, 3rd quartile; min-max)
|
(15, 65; 0–94)
|
(10, 72; 0–100)
|
|
Total propofol dose (mg) during intervention period, median
|
1,090
|
2,380
|
0.14
|
|
(1st, 3rd quartile; min-max)
|
(375, 2,965; 100–7,290)
|
(1,510, 3,730; 60–8,630)
|
|
Total alfentanil dose (mg) during intervention period, median
|
21.2
|
32.3
|
0.01
|
|
(1st, 3rd quartile; min-max)
|
(8.5, 27.9; 0.0–49.0)
|
(23.3, 49.8; 1.0–87.0)
|
